195 related articles for article (PubMed ID: 17563269)
1. Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes.
Smiley D; Umpierrez G
Expert Opin Pharmacother; 2007 Jun; 8(9):1353-64. PubMed ID: 17563269
[TBL] [Abstract][Full Text] [Related]
2. Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes.
Stafford JM; Elasy T
Vasc Health Risk Manag; 2007; 3(4):503-10. PubMed ID: 17969380
[TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone maleate/metformin hydrochloride: a new formulation therapy for type 2 diabetes.
Cox SL
Drugs Today (Barc); 2004 Jul; 40(7):633-43. PubMed ID: 15510236
[TBL] [Abstract][Full Text] [Related]
4. Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes.
Bailey CJ; Day C
Int J Clin Pract; 2004 Sep; 58(9):867-76. PubMed ID: 15529521
[TBL] [Abstract][Full Text] [Related]
5. Effect of metformin and rosiglitazone in a prepubertal boy with Alström syndrome.
Sinha SK; Bhangoo A; Anhalt H; Maclaren N; Marshall JD; Collin GB; Naggert JK; Ten S
J Pediatr Endocrinol Metab; 2007 Sep; 20(9):1045-52. PubMed ID: 18038714
[TBL] [Abstract][Full Text] [Related]
6. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
8. Metformin and pioglitazone: Effectively treating insulin resistance.
Staels B
Curr Med Res Opin; 2006; 22 Suppl 2():S27-37. PubMed ID: 16914073
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes.
Hällsten K; Virtanen KA; Lönnqvist F; Sipilä H; Oksanen A; Viljanen T; Rönnemaa T; Viikari J; Knuuti J; Nuutila P
Diabetes; 2002 Dec; 51(12):3479-85. PubMed ID: 12453903
[TBL] [Abstract][Full Text] [Related]
10. Effects of metformin and rosiglitazone on peripheral insulin resistance and β-cell function in obesity: a double-blind, randomized, controlled study.
Li X; Zhang N; Li Y; Shi Y; Li D; Xie Y; Xie Y; Ming J
J Int Med Res; 2011; 39(2):358-65. PubMed ID: 21672339
[TBL] [Abstract][Full Text] [Related]
11. Changes over time in glycemic control, insulin sensitivity, and beta-cell function in response to low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance.
Retnakaran R; Qi Y; Harris SB; Hanley AJ; Zinman B
Diabetes Care; 2011 Jul; 34(7):1601-4. PubMed ID: 21709296
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus.
Seufert J; Lübben G; Dietrich K; Bates PC
Clin Ther; 2004 Jun; 26(6):805-18. PubMed ID: 15262452
[TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone plus metformin: combination therapy for Type 2 diabetes.
Del Prato S; Volpe L
Expert Opin Pharmacother; 2004 Jun; 5(6):1411-22. PubMed ID: 15163284
[TBL] [Abstract][Full Text] [Related]
14. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
[TBL] [Abstract][Full Text] [Related]
15. Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study.
Karlsson HK; Hällsten K; Björnholm M; Tsuchida H; Chibalin AV; Virtanen KA; Heinonen OJ; Lönnqvist F; Nuutila P; Zierath JR
Diabetes; 2005 May; 54(5):1459-67. PubMed ID: 15855334
[TBL] [Abstract][Full Text] [Related]
16. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis.
Vanderpoel DR; Hussein MA; Watson-Heidari T; Perry A
Clin Ther; 2004 Dec; 26(12):2066-75. PubMed ID: 15823770
[TBL] [Abstract][Full Text] [Related]
17. Pioglitazone, rosiglitazone, and rosiglitazone + metformin: new drugs. Glitazone + oral antidiabetic combination: inadequately evaluated.
Prescrire Int; 2005 Aug; 14(78):133-9. PubMed ID: 16106595
[TBL] [Abstract][Full Text] [Related]
18. Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes.
Iozzo P; Hallsten K; Oikonen V; Virtanen KA; Parkkola R; Kemppainen J; Solin O; Lonnqvist F; Ferrannini E; Knuuti J; Nuutila P
Diabetes Care; 2003 Jul; 26(7):2069-74. PubMed ID: 12832315
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone/Metformin.
Wellington K
Drugs; 2005; 65(11):1581-92; discussion 1593-4. PubMed ID: 16033298
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
Strowig SM; Raskin P
Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
